TABLE 2.
Mouse anti-FALVAC-1A peptide titers found in ELISAsa
Epitope originb | Peptide | Immune reactivityc | Anti-FALVAC-1A peptide titer of pooled sera (10 mice)d
|
|||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
C57BL/6
|
B10.BR
|
B10.D2
|
ICR
|
|||||||||||||||||||
CRL-1005 | ISA-720 | QS-21 | AlPO4 | No adj. | CRL-1005 | ISA-720 | QS-21 | AlPO4 | No adj. | CRL-1005 | ISA-720 | QS-21 | AlPO4 | No adj. | CRL-1005 | ISA-720 | QS-21 | AlPO4 | No adj. | |||
CSP | p865 | B | 6,400 | 3,200 | 3,200 | 800 | 100 | 51,200 | 6,400 | 12,800 | 3,200 | 200 | 6,400 | 6,400 | 6,400 | 200 | 100 | 25,600 | 12,800 | 12,800 | 3,200 | 1,600 |
CSP | p843 | Th/Tc | 800 | 400 | - | - | 100 | 25,600 | 25,600 | 51,200 | 1,600 | 1,600 | 12,800 | 25,600 | 6,400 | - | - | 102,400 | 25,600 | 51,200 | 12,800 | 1,600 |
CSP | p867 | Th | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
MSP-1 | p844 | B | 3,200 | 6,400 | 3,200 | 3,200 | 100 | 51,200 | 3,200 | 25,600 | 6,400 | 1,600 | 12,800 | 12,800 | 6,400 | 100 | 100 | 6,400 | 12,800 | 6,400 | 100 | 100 |
MSP-1 | p845 | B | 800 | 400 | 800 | 400 | 100 | - | 12,800 | 200 | 1,600 | 400 | 6,400 | 6,400 | 3,200 | 1,600 | 400 | 51,200 | 25,600 | 25,600 | 6,400 | 1,600 |
LSA-1 | p846 | Tc | - | - | - | - | 6,400 | 1,600 | 100 | - | 400 | 800 | 800 | - | - | 100 | - | 100 | - | 800 | 100 | |
CSP | p847 | B | - | - | - | - | - | - | 200 | - | - | - | - | 400 | - | - | 100 | 800 | - | - | - | 100 |
AMA-1 | p848 | B | 6,400 | 1,600 | 6,400 | 1,600 | 100 | 6,400 | 800 | 25,600 | - | - | 1,600 | 800 | 1,600 | 800 | 100 | 12,800 | 12,800 | 6,400 | 800 | 100 |
AMA-1 | p849 | B | 3,200 | 3,200 | 12,800 | 3,200 | 100 | 6,400 | 6,400 | 25,600 | 6,400 | - | 1,600 | 6,400 | 6,400 | - | - | 12,800 | 12,800 | 12,800 | 6,400 | 1,600 |
RAP-1 | p866 | B | 12,800 | 6,400 | 12,800 | 6,400 | 800 | 25,600 | 6,400 | 51,200 | 25,600 | 1,600 | 25,600 | 25,600 | 51,200 | 6,400 | - | 102,400 | 25,600 | 12,800 | 25,600 | 1,600 |
LSA-1 | p851 | Tc | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBA-175 | p863 | B | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
MSP-2 | p853 | B | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
MSP-2 | p854 | B | 100 | - | - | - | 100 | - | - | - | - | - | - | - | - | - | - | 100 | - | - | - | - |
EBA-175 | p862 | B | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 6,400 | 400 | 3,200 | - | 100 |
AMA-1 | p856 | Tp | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1,600 | 1,600 | - | 1,600 | 100 |
AMA-1 | p857 | Tp | 1,600 | 1,600 | 12,800 | 1,600 | 100 | 25,600 | 3,200 | 3,200 | 3,200 | 1,600 | 6,400 | 6,400 | 3,200 | 400 | 100 | 51,200 | 12,800 | 12,800 | 25,600 | 1,600 |
EBA-175 | p864 | B | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
RAP-1 | p859 | Tp | 400 | - | - | - | 100 | - | - | 100 | - | - | - | - | - | - | - | 12,800 | 800 | 1,600 | 100 | 100 |
RAP-1 | p860 | Tp | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 100 | 200 | - | - | - |
MSP-1 | p861 | Tp | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 100 | 100 | 100 | - | - |
Four strains of mice were immunized on days 0, 14, and 28 with 10 μg FALVAC-1A formulated with the indicated adjuvants. Sera collected on day 42 (serum with peak antibody titer) were used for peptide ELISA. ELISA titers against each epitopic peptide were determined by titration. The order of epitopes is the same as in Table 1. In CSP, the first epitope, Th/Tc, KPKDELDYENDIEKKICKMEKCS runs continuously into the second Th epitope, SVFNVVNS. Antibody responses were determined jointly against the peptide KPKDELDYENDIEKKICKMEKCSSVFNVVNS.
The origin of the epitope is shown as follows: CSP, circumsporozoite protein; MSP-1, merozoite surface protein-1; LSA-1, liver stage antigen-1; AMA-1, apical membrane antigen-1; RAP-1, rhoptry-associated protein-1; EBA-175, erythrocyte binding antigen-175; MSP-2, merozoite surface protein-2.
The immune reactivity of each epitope (synthetic peptide) is shown as follows: B, B cell; Th/Tc, T helper and cytotoxic T cell; Th, T helper cell; Tc, cytotoxic T cell; Tp, T proliferative cell.
Four strains of mice (C57BL/6, B10.BR, B10.D2, and ICR) were immunized with 10 μg FALVAC-1A formulated with adjuvants (copolymer CRL-1005, Montanide ISA-720, QS-21, and AlPO4) or with no adjuvant (No adj.). Dashes indicated that the titer was <100.